A 67-year-old woman is hospitalized for an acute pulmonary embolism and has been receiving… — USMLE Step 3

A 67-year-old woman is hospitalized for an acute pulmonary embolism and has been receiving an intravenous unfractionated heparin infusion since admission. On hospital day 5, routine laboratory studies reveal a platelet count of $105,000/mm^3$ , which is a significant decrease from her admission baseline of $260,000/mm^3$ . Vital signs show temperature $37.1^\circ C$ ( $98.8^\circ F$ ), blood pressure $128/76$ mmHg, heart rate $88$ /min, and respiratory rate $16$ /min. She denies any epistaxis, hematuria, or melena, and there is no evidence of active bleeding. However, she complains of new-onset right calf pain. Physical examination shows right calf swelling and erythema. Which of the following are appropriate next steps in the evaluation and management of this patient? (Select all that apply)

Discontinue the unfractionated heparin infusion immediatelyAnswer
Initiate continuous intravenous argatrobanAnswer
Order an enzyme-linked immunosorbent assay (ELISA) for heparin-PF4 antibodiesAnswer
D
Transition anticoagulation to subcutaneous enoxaparin
E
Initiate oral warfarin therapy

Answer

The appropriate next steps are to immediately discontinue the unfractionated heparin infusion, initiate an alternative non-heparin anticoagulant such as argatroban, and order a heparin-PF4 antibody immunoassay.

This patient presents with a classic presentation of Heparin-Induced Thrombocytopenia (HIT) Type 2, characterized by a platelet count drop of greater than 50% occurring 5-10 days after heparin initiation, alongside a new thrombotic event (right calf DVT).

The 4T's score is used to determine the pretest probability of HIT:

Parameter	2 points	1 point	0 points
Thrombocytopenia	>50% drop, nadir ≥20k	30-50% drop or nadir <20k	<30% drop
Timing	Days 5-10	>Day 10 or unknown	<Day 4
Thrombosis	New confirmed thrombosis	Progressive/recurrent DVT	None
oTher causes	None evident	Possible	Definite

Because she has a high clinical probability based on her score, all forms of heparin must be immediately discontinued. Due to the extremely high risk of progressive thrombosis, an alternative non-heparin anticoagulant, such as the direct thrombin inhibitor argatroban, must be started empirically. Concurrently, a heparin-PF4 antibody immunoassay should be sent to confirm the diagnosis, though treatment must not be delayed while awaiting these results.

Step-by-Step Solution

Calculate the 4T's score to determine the pretest clinical probability of HIT.

The patient has a >50% platelet drop (2 points), timing of 5 days (2 points), and a new suspected thrombosis (2 points). This yields a high-probability score of 6-8 points.

Establishing the clinical probability of HIT dictates whether immediate intervention is required before laboratory confirmation is available.

Select the immediate management interventions for high-probability HIT.

Stop all heparin exposure and start a non-heparin anticoagulant (argatroban).

Heparin must be stopped to remove the immunologic trigger. However, alternative anticoagulation is still required due to the massive prothrombotic risk, evidenced by the new deep vein thrombosis.

Select the appropriate diagnostic test for confirmation.

Order a heparin-PF4 ELISA.

Confirmatory testing is necessary to guide long-term management and document the allergy, though it must not delay life-saving empirical treatment.

Key Concept

Management of Heparin-Induced Thrombocytopenia (HIT) Type 2

Estimated Time:1m 30s

Question

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Topics

More questions from this topic